Examining the Usage of Dopamine Blockers in OCD Patients
Information source: Sheba Medical Center
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Obsessive Compulsive Disorder
Phase: N/A
Status: Not yet recruiting
Sponsored by: Sheba Medical Center Official(s) and/or principal investigator(s):
Joseph Zohar, MD, Principal Investigator, Affiliation: Chaim Sheba Medical Center
Overall contact:
Leah Fostick, PhD, Phone: +972-3-5357805, Email: Leah.Fostick@sheba.health.gov.il
Summary
We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency
of usage, compare the course of the disease between those who receive and those who do not
receive Dopamine blockers, and efficacy of the treatment.
The study will be done in two stages: 1. Collecting information the usage of Dopamine
blockers from 150 OCD patients' files. 2. interviewing 60 patients to see the difference
those who receive and those who do not receive Dopamine blockers in their current severity of
disease.
Clinical Details
Study design: Cross-Sectional, Defined Population, Retrospective Study
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- DSM-IV diagnosis of OCD
Locations and Contacts
Leah Fostick, PhD, Phone: +972-3-5357805, Email: Leah.Fostick@sheba.health.gov.il
Chaim Sheba Medical Center, Ramat-Gan 52621, Israel
Additional Information
Last updated: July 16, 2007
|
